Systemic lupus erythematosus with diffuse alveolar hemorrhage  

作　　者：Rongxiu Huo Xinxiang Huang Jinying Lin 

机构地区：[1]Department of Rheumatology and Immunology,Guangxi Academy of Medical Sciences,The People’s Hospital of Guangxi Zhuang Autonomous Region,Nanning,Guangxi 530016,China

出　　处：《Chinese Medical Journal》2023年第23期2883-2885,共3页中华医学杂志（英文版）

摘　　要：To the Editor:Systemic lupus erythematosus(SLE)is an autoimmune disease characterized by the production of various autoantibodies.Disease prevalence is 20 to 70 per 100,000 among adults,and 1.89 to 25.7 per 100,000 among children.[1,2]The pathogenesis of SLE is associated with immune disorders,especially involving the activation of B and T cells,which can lead to abnormal antibodies with nuclear and cytosolic antigens from apoptotic cells of the immune complexes(ICs)removing the damaged cells,and excessive activation of the complement system,thus causing damage to target organs,such as the kidneys and lungs.

关 键 词：ERYTHEMATOSUS LUPUS ORGANS DAMAGE 

分 类 号：R593.241[医药卫生—内科学] R563[医药卫生—临床医学]